US: Sanofi seeks billions in EpiPen antitrust suit

US: Sanofi seeks billions in EpiPen antitrust suit

Sanofi wants Mylan to pay up to US$11.7 billion in damages for engaging in a scheme to squelch competition to its EpiPen allergy treatment, which became the center of a firestorm over drug price increases. The French drugmaker detailed its damages claim on Friday, August 9, as it urged a federal judge in Kansas City, […]

US: Celgene to pay Mylan $62M to resolve cancer drug antitrust case

US: Celgene to pay Mylan $62M to resolve cancer drug antitrust case

Mylan announced Celgene will pay it US$62 million to resolve a lawsuit alleging the drugmaker improperly stifled competition for its cancer treatment drugs Thalomid and Revlimid by preventing generic versions from entering the market. Mylan disclosed the settlement in a filing with the US Securities and Exchange Commission on Monday, July 29, days after Celgene […]

US: Pfizer and Mylan reportedly near merger deal for low-priced drugs

US: Pfizer and Mylan reportedly near merger deal for low-priced drugs

Pfizer plans to combine its off-patent business, which includes Lipitor cholesterol pills and male-impotence drug Viagra, with Mylan NV and form a generic drug giant. The Wall Street Journal reported Saturday, July 27, that pharma giants Pfizer and Mylan are nearing a deal that could create a global powerhouse in the low-price drug market. A […]

US: Mylan seeks dismissal of Sanofi’s EpiPen antitrust suit

US: Mylan seeks dismissal of Sanofi’s EpiPen antitrust suit

Mylan is urging a federal judge to reject rival drugmaker Sanofi’s claims the company engaged in a scheme to squelch competition to its EpiPen allergy treatment, which became the center of a political firestorm over price increases. Mylan in a brief filed on Friday in federal court in Kansas City, Kansas, argued Sanofi lacked evidence to support […]

US: Mylan antitrust lawsuit filed by 44 AGs transferred to PA federal court

US: Mylan antitrust lawsuit filed by 44 AGs transferred to PA federal court

A federal lawsuit filed by West Virginia and 43 other states against Mylan Pharmaceuticals has been transferred from the federal court in Connecticut to U.S. District Court for the Eastern District of Pennsylvania at Philadelphia. In a conditional transfer order, John W. Nichols, the clerk of the U.S. Judicial Panel on Multidistrict Litigation, noted that […]

US: EpiPen makers must face antitrust claims, judge rules

US: EpiPen makers must face antitrust claims, judge rules

A Kansas district court judge has dismissed motions by Mylan, Pfizer, and others to dismiss class action complaints accusing them of RICO Act violations, specifically, their activities aimed at monopolizing the market for emergency allergy med EpiPen (epinephrine). The lawsuit alleges Pfizer and Mylan engaged in “an illegal scheme to monopolize the market” for epinephrine […]

US: Humana sues generics manufacturers over price-fixing

US: Humana sues generics manufacturers over price-fixing

Humana has brought a lawsuit against 37 pharmaceutical companies including Novartis, Mylan, and Teva, alleging price fixing of numerous generic drugs. The conspiracy allegedly increased the profits of the drug makers and others working with them at the expense of consumers, the government, and private payers such as Humana, the lawsuit stated. The complaint, filed […]

Italy: Mylan faces new probe

Italy: Mylan faces new probe

Pharmaceutical company Mylan NV announced that certain employees of Mylan in Italy were served with search warrants issued by the public prosecutor’s office in Milan, Italy, seeking information concerning interactions with an Italian hospital and sales of certain reimbursable drugs. The company was not immediately available for additional details outside business hours. Shares of the […]

US: DAs get personal on pharma, name Mylan, Emcure execs

US: DAs get personal on pharma, name Mylan, Emcure execs

Mylan president Rajiv Malik has been named in an expanded federal lawsuit filed by attorneys general in nearly every state, that accuses Mylan and more than a dozen other drugmakers of conspiring to fix prices for generic drugs. The amended complaint, which state officials are asking federal court for permission to file, also names Satish […]

US: Mylan reaches EpiPen Settlment for $465m

US: Mylan reaches EpiPen Settlment for $465m

On August 17, Mylan and federal investigators finalized a US$465 million settlement of charges the drugmaker overcharged the government for the injection allergy medication EpiPen. Resolving an issue that fueled nationwide debate over soaring drug costs, the agreement ends an investigation that found Mylan avoided paying state Medicaid programs higher EpiPen rebates by improperly catagorizing […]